The Effect of Laparoscopic Gastric Banding Surgery on Plasma Levels of Appetite-Control, Insulinotropic, and Digestive Hormones

[1]  M. Monteiro,et al.  Increase in Ghrelin Levels After Weight Loss in Obese Zucker Rats is Prevented by Gastric Banding , 2007, Obesity surgery.

[2]  S. Bloom,et al.  Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass , 2007, Annals of surgery.

[3]  Claude Bouchard,et al.  Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.

[4]  Steven C Hunt,et al.  Long-term mortality after gastric bypass surgery. , 2007, The New England journal of medicine.

[5]  B. Wolfe,et al.  Bariatric surgery: a review of procedures and outcomes. , 2007, Gastroenterology.

[6]  M. Sundbom,et al.  Early Changes in Ghrelin following Roux-en-Y Gastric Bypass: Influence of Vagal Nerve Functionality? , 2007, Obesity surgery.

[7]  L. Lind,et al.  Meal suppression of circulating ghrelin is normalized in obese individuals following gastric bypass surgery , 2007, International Journal of Obesity.

[8]  J. Purnell,et al.  Changes in 24-h area-under-the-curve ghrelin values following diet-induced weight loss are associated with loss of fat-free mass, but not with changes in fat mass, insulin levels or insulin sensitivity , 2007, International Journal of Obesity.

[9]  A. Patriti,et al.  Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. , 2007, Annals of surgery.

[10]  D. Jun,et al.  Correlation Between Gastrointestinal Symptoms and Gastric Leptin and Ghrelin Expression in Patients with Gastritis , 2007, Digestive Diseases and Sciences.

[11]  A. Lacy,et al.  GLP-1 and Changes in Glucose Tolerance following Gastric Bypass Surgery in Morbidly Obese Subjects , 2006, Obesity surgery.

[12]  M. Crowell,et al.  Gut-Brain Neuropeptides in the Regulation of Ingestive Behaviors and Obesity , 2006, The American Journal of Gastroenterology.

[13]  F. Mégraud,et al.  Effects of Helicobacter pylori infection on gut appetite peptide (leptin, ghrelin) expression in elderly inpatients. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  G. Enzi,et al.  High Ghrelin Concentration is Not a Predictor of Less Weight Loss in Morbidly Obese Women Treated with Laparoscopic Adjustable Gastric Banding , 2006, Obesity surgery.

[15]  S. Skinner,et al.  Treatment of Mild to Moderate Obesity with Laparoscopic Adjustable Gastric Banding or an Intensive Medical Program , 2006, Annals of Internal Medicine.

[16]  Josep Vidal,et al.  Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects. , 2006, The Journal of clinical endocrinology and metabolism.

[17]  K. Flegal,et al.  Prevalence of overweight and obesity in the United States, 1999-2004. , 2006, JAMA.

[18]  Ian Janssen,et al.  Vascular Risks and Management of Obesity in Children and Adolescents , 2006, Vascular health and risk management.

[19]  D. Lauderdale,et al.  Trends in bariatric surgical procedures. , 2005, JAMA.

[20]  Jaw-Town Lin,et al.  A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. , 2005, Archives of internal medicine.

[21]  A. Bertoli,et al.  Transient increase of plasma ghrelin after laparoscopic adjustable gastric banding in morbid obesity. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[22]  J. Dixon,et al.  Laparoscopic adjustable gastric banding induces prolonged satiety: a randomized blind crossover study. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  K. Sugano,et al.  Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. , 2005, The Journal of clinical endocrinology and metabolism.

[24]  R. DiMarchi,et al.  Leptin: structure, function and biology. , 2005, Vitamins and hormones.

[25]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[26]  G. Frühbeck,et al.  Fasting Plasma Ghrelin Concentrations 6 Months after Gastric Bypass are not Determined by Weight Loss or Changes in Insulinemia , 2004, Obesity surgery.

[27]  H. Isomoto,et al.  Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. , 2004, The American journal of medicine.

[28]  M. Gagner,et al.  The Early Effect of the Roux-en-Y Gastric Bypass on Hormones Involved in Body Weight Regulation and Glucose Metabolism , 2004, Annals of surgery.

[29]  A. Lacy,et al.  Short-term effects of gastric bypass surgery on circulating ghrelin levels. , 2004, Obesity research.

[30]  G. Pacini,et al.  Plasma ghrelin in obesity before and after weight loss after laparoscopical adjustable gastric banding. , 2004, The Journal of clinical endocrinology and metabolism.

[31]  W. Buurman,et al.  Ghrelin, Leptin and Insulin Levels after Restrictive Surgery: a 2-Year Follow-up Study , 2004, Obesity surgery.

[32]  D. Cummings,et al.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution. , 2004, The Journal of clinical endocrinology and metabolism.

[33]  U. Keller,et al.  Changes of body weight and plasma ghrelin levels after gastric banding and gastric bypass. , 2004, Obesity research.

[34]  Y. Sugisaki,et al.  Effect of Helicobacter pylori Infection on Ghrelin Expression in Human Gastric Mucosa , 2004, The American Journal of Gastroenterology.

[35]  G. Wittert,et al.  Hormonal Changes after Roux-en Y Gastric Bypass for Morbid Obesity and the Control of Type-II Diabetes Mellitus , 2004, The American surgeon.

[36]  F. Russo,et al.  Effect of Helicobacter pylori Infection on Gastric Emptying and Gastrointestinal Hormones in Dyspeptic and Healthy Subjects , 2004, Digestive Diseases and Sciences.

[37]  L. Kuller,et al.  Effect of Laparoscopic Roux-En Y Gastric Bypass on Type 2 Diabetes Mellitus , 2003 .

[38]  G. Silecchia,et al.  Different plasma ghrelin levels after laparoscopic gastric bypass and adjustable gastric banding in morbid obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[39]  G. Frost,et al.  Pancreatic polypeptide reduces appetite and food intake in humans. , 2003, The Journal of clinical endocrinology and metabolism.

[40]  L. Lind,et al.  Ghrelin and adipose tissue regulatory peptides: effect of gastric bypass surgery in obese humans. , 2003, The Journal of clinical endocrinology and metabolism.

[41]  M. Roden,et al.  Ghrelin concentrations in morbidly obese patients after adjustable gastric banding. , 2003, The New England journal of medicine.

[42]  M. Ohrvall,et al.  Reduction in serum pepsinogen I after roux-en-Y gastric bypass , 2003, Journal of Gastrointestinal Surgery.

[43]  K. Cianflone,et al.  Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[44]  M. Blaser,et al.  Responses of Endoscopy Patients in Ladakh, India, to Helicobacter pylori Whole-Cell and CagA Antigens , 2002, Clinical and Vaccine Immunology.

[45]  E. Dellinger,et al.  Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. , 2002, The New England journal of medicine.

[46]  R. Klaghofer,et al.  Impact of Gastric Banding on Eating Behavior and Weight , 2002, Obesity surgery.

[47]  B. Wisse,et al.  A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. , 2001, Diabetes.

[48]  M. Blaser,et al.  Helicobacter pylori seropositivity and subsite-specific gastric cancer risks in Linxian, China. , 2001, Journal of the National Cancer Institute.

[49]  R. Considine,et al.  Serum immunoreactive-leptin concentrations in normal-weight and obese humans. , 1996, The New England journal of medicine.

[50]  M. Blaser,et al.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. , 1995, Cancer research.

[51]  M Ariet,et al.  Determination of ideal body weight for drug dosage calculations. , 1983, American journal of hospital pharmacy.